1
Roll Calls
TRANQ Research Act of 2023
Policy Area: Science, Technology, Communications
Sponsor: Rep. Collins, Mike [R-GA-10] (R-GA)
Latest Action (2023-12-19): Became Public Law No: 118-23.
Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.
Subjects: Advanced technology and technological innovations, Chemistry, Congressional oversight, Drug trafficking and controlled substances, Higher education, Research administration and funding, Science and engineering education
Filter by Yea, Nay, or Absent
How members voted on HR1734. 363 total positions across all roll calls for this bill.
| Member | Date | Question | Vote | Result |
|---|---|---|---|---|
| Robert B. Aderholt (R-Alabama) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Jake Auchincloss (D-Massachusetts) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Mark E. Amodei (R-Nevada) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Alma S. Adams (D-North Carolina) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Pete Aguilar (D-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Rick W. Allen (R-Georgia) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Jodey C. Arrington (R-Texas) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Mark Alford (R-Missouri) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Sanford D. Bishop (D-Georgia) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Cliff Bentz (R-Oregon) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Stephanie I. Bice (R-Oklahoma) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Lauren Boebert (R-Colorado) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Gus M. Bilirakis (R-Florida) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Vern Buchanan (R-Florida) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Suzanne Bonamici (D-Oregon) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Joyce Beatty (D-Ohio) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Barr (R-Kentucky) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Julia Brownley (D-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Ami Bera (D-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Brian Babin (R-Texas) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Donald S. Beyer (D-Virginia) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Mike Bost (R-Illinois) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Brendan F. Boyle (D-Pennsylvania) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Don Bacon (R-Nebraska) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Banks (R-Indiana) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Nanette Diaz Barragán (D-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Jack Bergman (R-Michigan) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Biggs (R-Arizona) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Lisa Blunt Rochester (D-Delaware) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Troy Balderson (R-Ohio) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| James R. Baird (R-Indiana) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Tim Burchett (R-Tennessee) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Shontel M. Brown (D-Ohio) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Aaron Bean (R-Florida) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Nikki Budzinski (D-Illinois) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Eric Burlison (R-Missouri) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Josh Brecheen (R-Oklahoma) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Becca Balint (D-Vermont) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Ken Calvert (R-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| James E. Clyburn (D-South Carolina) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Kat Cammack (R-Florida) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| John R. Carter (R-Texas) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Tom Cole (R-Oklahoma) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Ed Case (D-Hawaii) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Costa (D-California) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Emanuel Cleaver (D-Missouri) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Henry Cuellar (D-Texas) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Kathy Castor (D-Florida) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Yvette D. Clarke (D-New York) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
| Steve Cohen (D-Tennessee) | 2023-05-11 | 2/3 Yea-And-Nay | Yea | Passed |
Showing 50 of 363 positions. JavaScript-enabled view supports filter by Yea/Nay/Absent and pagination.
Interactive features require JavaScript. Static data shown above.
HR1734 is the TRANQ Research Act of 2023, introduced in the House of the 119th U.S. Congress by Rep. Collins, Mike [R-GA-10] (R-GA). Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.
HR1734 was sponsored by Rep. Collins, Mike [R-GA-10] (R-GA). Cosponsors and roll-call positions are listed on this page.
As of 2023-12-19, HR1734 Became Public Law No: 118-23..
HR1734 has had 1 roll-call vote on record. The most recent: 2023-05-11 — 2/3 Yea-And-Nay (Passed).
HR1734 is categorized under "Science, Technology, Communications." Browse other bills in this area at /topic-science-technology-communications/.
Each member’s vote is shown on this page, with party affiliation, state, and the official vote question. Click any member to see their full voting record.